|  | Fold A | Fold B | ||
MLH1 | Â | Variant type | Variant type | ||
 |  | Pathogenic | Benign | Pathogenic | Benign |
 HWA Call | Pathogenic | 24880 | 60 | 24836 | 35 |
 | Benign | 176 | 49748 | 166 | 49765 |
 | No Call | 444 | 692 | 498 | 700 |
 Total Trials | 25500 | 50500 | 25500 | 50500 | |
 PPV | 0.9962 | 0.9978 | |||
 NPV | 0.9978 | 0.9979 | |||
MSH2 | Variant Type | Variant Type | |||
 |  | Pathogenic | Benign | Pathogenic | Benign |
 HWA Call | Pathogenic | 24775 | 12 | 24262 | 14 |
 | Benign | 111 | 50329 | 164 | 50243 |
 | No Call | 614 | 159 | 1074 | 243 |
 Total Trials | 25500 | 50500 | 25500 | 50500 | |
 PPV | 0.9988 | 0.9986 | |||
 NPV | 0.9991 | 0.9987 | |||
MSH6 | Variant Type | Variant Type | |||
 |  | Pathogenic | Benign | Pathogenic | Benign |
 HWA Call | Pathogenic | 23787 | 9 | 24014 | 25 |
 | Benign | 180 | 50262 | 88 | 49754 |
 | No Call | 1533 | 229 | 1398 | 721 |
 Total Trials | 25500 | 50500 | 25500 | 50500 | |
 PPV | 0.9987 | 0.9965 | |||
 NPV | 0.9990 | 0.9995 |